TWO Postdoctoral Fellows - Parkinson's Research

Van Andel Research Institute
Job Location
333 Bostwick Ave NE
Grand Rapids, MI 49503
$47,500 - $54,000
  • Medical, Dental, and Vision insurance
  • Institute paid Life and AD&D insurance
  • Short and Long Term Disability insurance
  • Voluntary Term Life and AD&D Insurance
  • Flexible Spending Accounts for medical and dependent care
  • Paid Vacation Days. 
  • 5 days of personal time off (PTO) 
  • Nine (9) Holidays
  • 401k Retirement Savings Plan 
  • Long Term Care Insurance
  • Paid Parking 
Job Description

Van Andel Research Institute’s P. Brundin Laboratory, under the direction of Patrik Brundin, M.D., Ph.D., has 2 positions available for Postdoctoral Fellows.


The Patrik Brundin lab focus on pathogenetic mechanisms and pharmacological treatment in cell and animal models of Parkinson's disease. They also study cell replacement therapy with stem cells in attempts to repair brains in animal models of parkinsonism. The group's mission is to understand neurodegenerative diseases and develop new therapies that are of benefit to patients and their caregivers.


Recently, the lab been involved in one of the most promising developments for a cure, or at least progress in fighting Parkinson’s disease. A new investigational drug originally developed for type 2 diabetes is being readied for human clinical trials in search of the world's first treatment to impede the progression of Parkinson's disease following publication of the lab’s new research.


Both of these postdoctoral positions are available IMMEDIATELY and for motivated scientists who meets the qualifications and description outlined below.


One of the fellows will investigate the contribution of a genetic mutation linked to Parkinson’s disease to alpha-synuclein pathogenesis. The overall goal of the project is to study the alpha-synuclein pathology in the context of a Parkinson’s disease-linked mutation. The candidate will use established model systems to determine effects of this mutation. The results from these studies could lead to development of novel therapeutic strategies to improve clinical outcomes of Parkinson’s disease.


The other fellow will investigate two experimental compounds in pre-clinical model systems of Parkinson’s disease. The overall goal of the project is to study novel treatments that may impact Parkinson’s disease in preclinical models. The candidate will use established model systems to determine effects of these compounds. The results from these studies could lead to development of novel therapeutic strategies to improve clinical outcomes of Parkinson’s disease.


Specifically, we are interested in candidates with a background in neuroscience and Parkinson’s disease.



  • A Ph.D. or M.D./Ph.D. in neuroscience, biochemistry, and/or molecular and cell biology with expertise in Parkinson’s disease.
  • Experience with mouse models of neurological disease and knowledge of brain morphology are expected.
  • Previous experience with molecular and cell biology techniques, stereotaxic surgery, and mouse behavioral studies are also expected.
  • A strong record of high-impact peer-reviewed publications is highly desirable.
  • Must provide the names of three individuals who can provide recommendations and present a scientific seminar describing his or her previous research.


Description of a Successful Candidate:

  • A self-motivated and driven individual who is able to exhibit exceptional research productivity and take responsibility for independent management of the project.
  • A detail-oriented researcher that thinks critically to effectively design experiments and solve complex research problems.
  • A strong ability to take initiative and work independently, as well as in a team environment.
  • A collaborative, hands-on researcher who proactively shares knowledge and expertise with lab members.
  • Excellent written and oral communication skills.
How to Apply

Qualified applicants should provide a cover letter outlining research experience and interests, a curriculum vitae, and the names and address of three references by visiting    


If you possess these attributes and desire to help us drive science from the bench to the clinic; while benefiting from a highly generous compensation package; we would welcome speaking with you and encourage you to apply today.


VAI is actively striving to diversify its workforce and strongly encourages qualified individuals from underrepresented groups to apply. Van Andel Institute is an EEO and Affirmative Action Employer.


This position will be open until filled. If you have any difficulty uploading your application or any questions, please email Eric Miller at [email protected].  

About Our Organization

Van Andel Research Institute (VARI), the research division of VAI, is dedicated to determining the epigenetic, genetic, molecular and cellular origins of cancer, Parkinson’s and other diseases and translating those findings into effective therapies. The Institute’s scientists work in on-site laboratories and participate in collaborative partnerships that span the globe.


Van Andel Research Institute is located in downtown Grand Rapids, MI which is the second largest city in Michigan and the largest city in West Michigan. Grand Rapids offers a remarkable combination of cosmopolitan atmosphere and small town warmth, known for its philanthropic and sustainability-driven community, and is ranked one of "America's Top 100 Places to Live."


Located on the banks of the Grand River, Grand Rapids offers all the big-city excitement you'd expect from a million-resident metropolis, featuring hundreds of restaurants and nightspots, theaters, museums, sports and concerts. The safe and clean downtown is surrounded by an eclectic mix of walk-able neighborhoods. 

With a medical and life sciences industry boom, strong entrepreneurial activity, dedication to green building and living, and innovative employers, Grand Rapids' diverse economy continues to grow, offering endless career opportunities.

New study finds bias against female lecturers among student course evaluations, the Economist reports.

A research duo finds that science and technology graduate students who turn away from academic careers do so because of changes in their own interests.

Students whose classmates are interested in science are more likely to think about a career in science, technology, engineering, and mathematics, a new study says.

CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.